VBL raises $24M after boost from ovarian cancer data

VBL Therapeutics Ltd. (NASDAQ:VBLT) raised $24 million on Tuesday through the sale of 4.4 million shares

Read the full 162 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE